TY - JOUR
T1 - Biomaterials for stem cell culture and seeding for the generation and delivery of cardiac myocytes
AU - Castells-Sala, Cristina
AU - Semino, Carlos E.
PY - 2012/12
Y1 - 2012/12
N2 - PURPOSE OF REVIEW: Present an overview of last year's advances in stem cell delivery for cardiac tissue engineering. RECENT FINDINGS: Several promising novel biomaterial platforms to improve myocardial tissue repair/regeneration and local neovascularization using cellular therapy have been developed. SUMMARY: Still today, a clear statement on cellular therapy efficacy cannot be made but nonetheless, as we describe in this review, several improved in-vivo applications have already been initiated. The newest tissue engineering platforms have basically two main objectives: to improve low cell engraftment and viability into the hostile environment of the infarcted tissue; and to promote neoformation of functional myocardial tissue. With the idea to solve these issues many groups are presently working on the association of stem cells with novel biomaterials, providing an initial appropriate microenvironment (scaffold) for successful cell transplantation, proper differentiation and improved cardiac function.
AB - PURPOSE OF REVIEW: Present an overview of last year's advances in stem cell delivery for cardiac tissue engineering. RECENT FINDINGS: Several promising novel biomaterial platforms to improve myocardial tissue repair/regeneration and local neovascularization using cellular therapy have been developed. SUMMARY: Still today, a clear statement on cellular therapy efficacy cannot be made but nonetheless, as we describe in this review, several improved in-vivo applications have already been initiated. The newest tissue engineering platforms have basically two main objectives: to improve low cell engraftment and viability into the hostile environment of the infarcted tissue; and to promote neoformation of functional myocardial tissue. With the idea to solve these issues many groups are presently working on the association of stem cells with novel biomaterials, providing an initial appropriate microenvironment (scaffold) for successful cell transplantation, proper differentiation and improved cardiac function.
KW - cellular therapy
KW - growth factors
KW - myocardial infarct
KW - scaffolds
KW - tissue engineering
UR - http://www.scopus.com/inward/record.url?scp=84870249863&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_univeritat_ramon_llull&SrcAuth=WosAPI&KeyUT=WOS:000311107100016&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1097/MOT.0b013e32835a34a6
DO - 10.1097/MOT.0b013e32835a34a6
M3 - Review
C2 - 23080064
AN - SCOPUS:84870249863
SN - 1087-2418
VL - 17
SP - 681
EP - 687
JO - Current Opinion in Organ Transplantation
JF - Current Opinion in Organ Transplantation
IS - 6
ER -